Liver Resection for Nonalcoholic Fatty Liver Disease-Associated Hepatocellular Carcinoma

被引:61
作者
Koh, Ye Xin [1 ]
Tan, Hiang Jin [1 ]
Liew, Yi Xin [2 ]
Syn, Nicholas [1 ]
Teo, Jin Yao [1 ,4 ]
Lee, Ser Yee [1 ,4 ]
Goh, Brian K. P. [1 ,4 ]
Goh, George B. B. [3 ,4 ]
Chan, Chung Yip [1 ,4 ]
机构
[1] Singapore Gen Hosp, Dept Hepatopancreatobiliary & Transplant Surg, 20 Coll Rd, Singapore 169856, Singapore
[2] Singapore Gen Hosp, Dept Pharm, Singapore, Singapore
[3] Singapore Gen Hosp, Dept Gastroenterol & Hepatol, Singapore, Singapore
[4] Duke Natl Univ Singapore, Singapore, Singapore
关键词
NAFLD; STEATOHEPATITIS; SURVIVAL;
D O I
10.1016/j.jamcollsurg.2019.07.012
中图分类号
R61 [外科手术学];
学科分类号
摘要
BACKGROUND: Nonalcoholic fatty liver disease (NAFLD)-related hepatocellular carcinoma (HCC) is on the rise worldwide, but data on long-term outcomes after curative operations are limited. The primary aim of this study was to characterize the perioperative and long-term outcomes after liver resection. The secondary aim was to investigate the influence of the histologic severity of nonalcoholic steatohepatitis and its impact on perioperative outcomes and long-term survival. METHODS: A total of 996 patients who underwent liver resection for HCC in our institution were analyzed. Patients were categorized into subgroups of NAFLD vs non-NAFLD HCC based on histologic evidence of hepatic steatosis. Comparisons of patients' demographic, clinical, and surgical characteristics; postoperative complications; and survival outcomes were performed. RESULTS: Eight hundred and forty-four patients had non-NAFLD HCC and 152 patients had NAFLD HCC. Comorbidities were significantly more common in the NAFLD group (p < 0.0001). In the non-NAFLD group, larger median tumor size, higher liver cirrhosis, and lower median neutrophil to lymphocyte ratio were observed (p < 0.0001). The NAFLD group had a greater amount of intraoperative blood loss, more postoperative complications, and longer length of stay. Five-year overall survival was significantly better in the NAFLD group (p = 0.0355). Significant factors that contribute to poorer survival outcomes include age, congestive cardiac failure, Child-Pugh's class B, cirrhosis, tumor size, multinodularity, and R1 resection. For NAFLD group, patients with abnormal parenchyma showed poorer survival and 5-year overall survival rates (64.8% vs 75.6%; p = 0.2291). CONCLUSIONS: Nonalcoholic fatty liver disease-related HCC is associated with greater surgical morbidity and post-hepatectomy liver failure. Despite this, long-term survival outcomes are favorable compared with non-NAFLD etiologies. ((C) 2019 by the American College of Surgeons. Published by Elsevier Inc. All rights reserved.)
引用
收藏
页码:467 / +
页数:13
相关论文
共 50 条
[31]   Diabetes and Risk of Hepatocellular Carcinoma in Cirrhosis Patients with Nonalcoholic Fatty Liver Disease [J].
Teng, Pai-Chi ;
Huang, Daniel Q. ;
Lin, Ting-Yi ;
Noureddin, Mazen ;
Yang, Ju Dong .
GUT AND LIVER, 2023, 17 (01) :24-33
[32]   Evaluating the roles of microRNAs associated with nonalcoholic fatty liver disease in hepatocellular carcinoma tumorigenesis: a systematic review and network analysis [J].
Peng, Qinghua ;
Zhu, Xiaoning ;
Jiang, Yuanyuan ;
Peng, Mengyun ;
Zheng, Ding ;
Wang, Xiaodong ;
Cheah, Yoke Kqueen ;
Wang, Jing .
FRONTIERS IN MEDICINE, 2024, 11
[33]   Nonalcoholic Fatty Liver Disease [J].
Isaacs, Scott .
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2023, 52 (01) :149-164
[34]   Influence of Nonalcoholic Fatty Liver Disease With Increased Liver Enzyme Levels on the Risk of Cirrhosis and Hepatocellular Carcinoma [J].
Huang, Yu-Han ;
Chan, Chi ;
Lee, Hye-Won ;
Huang, Claire ;
Chen, Yen-Ju ;
Liu, Po-Chun ;
Lu, Sheng-Nan ;
Chuang, Wan-Long ;
Huang, Jee-Fu ;
Yu, Ming-Lung ;
Koshiol, Jill ;
Lee, Mei-Hsuan .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2023, 21 (04) :960-969
[35]   Short- and long-term outcomes of laparoscopic liver resection for non-alcoholic fatty liver disease-associated hepatocellular carcinoma: a retrospective cohort study [J].
Watanabe, Yukihiro ;
Aikawa, Masayasu ;
Oshima, Yuhei ;
Kato, Tomotaka ;
Takase, Kenichiro ;
Watanabe, Yuichiro ;
Okada, Katsuya ;
Okamoto, Kojun ;
Koyama, Isamu .
HPB, 2023, 25 (12) :1573-1586
[36]   Non-alcoholic fatty liver disease-associated hepatocellular carcinoma: effect of hepatic steatosis on major hepatocellular carcinoma features at MRI [J].
Thompson, Scott M. ;
Garg, Ishan ;
Ehman, Eric C. ;
Sheedy, Shannon P. ;
Bookwalter, Candice A. ;
Carter, Rickey E. ;
Roberts, Lewis R. ;
Venkatesh, Sudhakar K. .
BRITISH JOURNAL OF RADIOLOGY, 2018, 91 (1092)
[37]   Statin Use and Reduced Hepatocellular Carcinoma Risk in Patients With Nonalcoholic Fatty Liver Disease [J].
Zou, Biyao ;
Odden, Michelle C. ;
Nguyen, Mindie H. .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2023, 21 (02) :435-+
[38]   Integrative Genomic Signatures Of Hepatocellular Carcinoma Derived from Nonalcoholic Fatty Liver Disease [J].
Frades, Itziar ;
Andreasson, Erik ;
Maria Mato, Jose ;
Alexandersson, Erik ;
Matthiesen, Rune ;
Martinez-Chantar, Ma Luz .
PLOS ONE, 2015, 10 (05)
[39]   Molecular Mechanisms: Connections between Nonalcoholic Fatty Liver Disease, Steatohepatitis and Hepatocellular Carcinoma [J].
Kanda, Tatsuo ;
Goto, Taichiro ;
Hirotsu, Yosuke ;
Masuzaki, Ryota ;
Moriyama, Mitsuhiko ;
Omata, Masao .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (04)
[40]   Risk factors of hepatocellular carcinoma associated with nonalcoholic fatty liver disease: Systematic review and meta-analysis [J].
Yin, Huimin ;
Yan, Zhanjie ;
Zhao, Fangcheng .
TECHNOLOGY AND HEALTH CARE, 2024, 32 (06) :3943-3954